The Healthcare Interoperability Solutions Market is Poised for a ~13% Growth Rate by 2029.

The primary drivers of the market are the growing need for efficient and cost-effective healthcare delivery, government initiatives and regulations aimed at improving patient care and safety, the growing adoption of electronic health records (EHRs), the increasing demand from patients for data access, the advancement of technology in healthcare IT, and the shift towards value-based […]

Continue Reading

The High-Performance Liquid Chromatography (HPLC) Market Aims for a 4-6% Growth Rate by 2029.

The HPLC market is expanding due to the growing need for analytical procedures with high sensitivity, precision, and efficiency. Technological improvements, increased investment in research & development, and expanded HPLC applications all help to drive market growth. High-performance liquid chromatography (HPLC) is a reliable analytical technology used to separate, identify, and quantify distinct components in […]

Continue Reading

Global Renal Denervation (RDN) Market is estimated at $140 million (2022) and is developing at a profitable CAGR of 40%.

Resistant hypertension is a blood pressure that remains elevated above target levels despite use of anti-hypertensive medications. About 12-15% of the population treated for high blood pressure suffers from resistant hypertension. Renal denervation is a minimally invasive procedure used to treat resistant hypertension. As the geriatric population is growing, the number of people suffering from […]

Continue Reading

Global Remote and Predictive Medical Equipment Maintenance Market is poised to observe a double-digit growth

Remote and predictive maintenance of medical equipment is becoming crucial due to the growing digitalization and move toward connected devices and cloud-based infrastructure. The medical device industry is now increasingly embracing the use of advanced technologies like The Internet of Things (IoT), Artificial Intelligence (AI), and data analytics to resolve problems faster and effectively. The […]

Continue Reading

Global Liquid Biopsy Market is projected to witness a healthy CAGR of 17% by 2026

Rising incidence and prevalence of cancer worldwide, increasing preference for Non-Invasive procedures/therapies, growing awareness regarding liquid biopsy, and technological advancement in cancer diagnosis using liquid biopsy are some of the key factors driving the global liquid biopsy market. Liquid Biopsy is a procedure of sampling and analyzing non-solid biological tissues (such as blood and others), […]

Continue Reading

Global Amniotic Products Market is projected to grow at a CAGR of 8% to reach $1 billion by 2026.

Amniotic-derived products, including amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that are considered a potential treatment option for augmentation of joint inflammation and healing. An amniotic membrane or amnion is a thin membrane forming a closed sac around the embryos or fetuses, and mammals and containing the amniotic fluid. The most common types of […]

Continue Reading

The Medical Mobility Aids Market is Set to Grow at a Steady CAGR of 6-7% in the Coming Years.

The expanding aging population, increasing frequency of impairments, technical improvements in mobility aids, and rising healthcare spending internationally are all key growth drivers for the market. These factors, taken together, lead to the increased demand for mobility aids, particularly among the elderly and those with mobility limitations, resulting in market growth. Medical mobility aids are […]

Continue Reading

Global e-prescribing Market is projected to have an exponential growth rate of 24-26% by 2029.

Key factors driving market growth include e-prescribing benefits (such as improved patient safety, reduced prescription and medication errors, instant clinical alerts, prescription fulfillment tracking, and so on), Covid-19, a favorable regulatory environment in selected countries, increased use of telemedicine, an emerging focus on reducing controlled substance abuse, adoption of EHR solutions, government initiatives, and incentive […]

Continue Reading

Global interventional cardiology devices market, valued at $6.7 billion in 2021, is expected to rise at a pace of 2 to 3% by 2026.

Some of the main factors propelling the market’s growth are the aging population and the corresponding rise in coronary artery diseases, the rising number of diabetes cases and the associated elevated risk of coronary heart disease, technological advancements in interventional cardiology devices, and favorable reimbursements for interventional cardiology procedures. Interventional cardiology is a subspecialty of cardiology that uses nonsurgical, catheter-based therapies for structural heart problems. It uses catheters and sheaths, guidewires, balloons, stents, vascular closure devices, atherectomy devices, intravascular ultrasonography (IVUS), and other devices to treat restricted arteries, damaged or weakened blood vessels, heart valve abnormalities, and congenital heart illnesses. Get a Free Sample Report of our Research : https://meditechinsights.com/interventional-cardiology-devices-market/request-sample/ APAC Interventional Cardiology Devices Market to See Highest Growth in the Next Five Years A increasing frequency of cardiovascular illnesses and hypertension, a higher level of unmet clinical demands, and rising affluence are all offering significant prospects for the interventional […]

Continue Reading

Global cardiopulmonary devices market, estimated to be worth $2.8 billion in 2021, is expected to expand at a pace of 5% by 2026.

The market for cardiopulmonary devices is expected to grow due to a number of factors, including an aging population, an increase in the prevalence of cardiopulmonary diseases, a rise in demand for these devices as a result of COVID-19, an increase in the number of ECMO centers, growing awareness of the devices, and an increase […]

Continue Reading